Cargando…

Efficacy of trimetazidine and plasmin combined with alprostadil in treatment of lower extremity arteriosclerosis obliterans

Clinical efficacy of trimetazidine and plasmin combined with alprostadil in the treatment of lower extremity arteriosclerosis obliterans was investigated. A retrospective analysis was performed on 132 patients with lower extremity arteriosclerosis obliterans treated in Yantai Yuhuangding Hospital fr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yong, Jun, Wang, Yingchun, Xing, Shouli, Bi, Yufang, Li, Ning, Zhao, Shanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488991/ https://www.ncbi.nlm.nih.gov/pubmed/31086587 http://dx.doi.org/10.3892/etm.2019.7476

Ejemplares similares

Comparison of efficacy between trimetazidine and cilostazol in the treatment of arteriosclerosis obliterans in lower extremity
por: Hu, Min, et al.
Publicado: (2019)

Clinical Efficacy of Interventional Therapy on Lower Extremity Arteriosclerosis Obliterans and Prognostic Factors
por: Xiao, Deshuang, et al.
Publicado: (2022)

Retracted: Clinical Efficacy of Interventional Therapy on Lower Extremity Arteriosclerosis Obliterans and Prognostic Factors
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Expression and clinical significance of HSP27 and its phosphorylation in lower extremity arteriosclerosis obliterans
por: Bai, Junqing, et al.
Publicado: (2020)

Virtual Reality-Assisted Percutaneous Transluminal Angioplasty for Interventional Treatment of Lower-Extremity Arteriosclerosis Obliterans
por: Zhou, Ruhang, et al.
Publicado: (2021)

Predictive Value of Contrast-Enhanced Ultrasound in Chemical Lumbar Sympathectomy for End-Stage Arteriosclerosis Obliterans of the Lower Extremities
por: Wu, Yue, et al.
Publicado: (2022)

Retracted: Virtual Reality-Assisted Percutaneous Transluminal Angioplasty for Interventional Treatment of Lower-Extremity Arteriosclerosis Obliterans
por: Healthcare Engineering, Journal of
Publicado: (2023)

The clinical significance of serum HMGB1 in patients with lower extremity arteriosclerosis obliterans after interventional vascular restenosis
por: Yang, Bo, et al.
Publicado: (2023)

Novel Insight Into Long-Term Risk of Major Adverse Cardiovascular and Cerebrovascular Events Following Lower Extremity Arteriosclerosis Obliterans
por: Sun, Ji, et al.
Publicado: (2022)

Effects of Valsartan on Restenosis in Patients with Arteriosclerosis Obliterans of the Lower Extremities Undergoing Interventional Therapy: A Prospective, Randomized, Single-Blind Trial
por: Yao, Wei, et al.
Publicado: (2020)

Venous thrombosis and arteriosclerosis obliterans of lower extremities in a very severe patient with 2019 novel coronavirus disease: a case report
por: Zhou, Bo, et al.
Publicado: (2020)

Increased Level of Tim-3(+)PD-1(+)CD4(+)T Cells With Altered Function Might Be Associated With Lower Extremity Arteriosclerosis Obliterans
por: Cui, Liyuan, et al.
Publicado: (2022)

miR-21 regulates vascular smooth muscle cell function in arteriosclerosis obliterans of lower extremities through AKT and ERK1/2 pathways
por: Huang, Shuichuan, et al.
Publicado: (2018)

Relationship between Angiotensin II, Vascular Endothelial Growth Factor, and Arteriosclerosis Obliterans
por: Liu, Yulian, et al.
Publicado: (2023)

Microarray Expression Profile and Bioinformatic Analysis of Circular RNA in Human Arteriosclerosis Obliterans
por: Zhou, Yu, et al.
Publicado: (2023)

HSPB1 Regulates Autophagy and Apoptosis in Vascular Smooth Muscle Cells in Arteriosclerosis Obliterans
por: Chen, Keqin, et al.
Publicado: (2022)

Effect of Recombinant Netrin-1 Protein Combined with Peripheral Blood Mesenchymal Stem Cells on Angiogenesis in Rats with Arteriosclerosis Obliterans
por: Zeng, Jie, et al.
Publicado: (2022)

Loss of GRB2 associated binding protein 1 in arteriosclerosis obliterans promotes host autophagy
por: Ye, Meng, et al.
Publicado: (2021)

Application of E-coach chronic disease management model in rehabilitation management of patients with arteriosclerosis obliterans
por: Yuan, You-Yuan, et al.
Publicado: (2023)

MicroRNA-31 promotes arterial smooth muscle cell proliferation and migration by targeting mitofusin-2 in arteriosclerosis obliterans of the lower extremitie
por: Huang, Shuichuan, et al.
Publicado: (2018)

Combined treatment of diabetic nephropathy with alprostadil and calcium dobesilate
por: Qin, Lili, et al.
Publicado: (2017)

Efficacy of alprostadil for preventing of contrast-induced nephropathy: A meta-analysis
por: Zhang, Jing-Zhan, et al.
Publicado: (2017)

Ameliorative effects of the traditional Chinese medicine formula Qing-Mai-Yin on arteriosclerosis obliterans in a rabbit model
por: Zhang, Lei, et al.
Publicado: (2020)

Neutrophil gelatinase-associated lipocalin as an early predictor of contrast-induced nephropathy following endovascular therapy for arteriosclerosis obliterans
por: Liu, Zhenjie, et al.
Publicado: (2020)

MicroRNA-30a-3p: a potential noncoding RNA target for the treatment of arteriosclerosis obliterans
por: Zhang, Mao, et al.
Publicado: (2023)

Clinical Efficacy of Alprostadil Combined with α-lipoic Acid in the Treatment of Elderly Patients with Diabetic Nephropathy
por: Hong, Yan, et al.
Publicado: (2017)

Treatment of Cholesterol Embolism With Corticosteroids and Alprostadil
por: Jung, Seung Mook
Publicado: (2019)

Trimetazidine in Heart Failure
por: Shu, Hongyang, et al.
Publicado: (2021)

Effects of Drug-Coated Balloon Therapy on CT Imaging Results and Levels of Vascular Inflammatory Cytokines in Patients with Arteriosclerosis Obliterans Lesions
por: Yang, Yanlin
Publicado: (2022)

Author Correction: Efficacy of alprostadil for preventing of contrast-induced nephropathy: A meta-analysis
por: Zhang, Jing-Zhan, et al.
Publicado: (2019)

Arteriosclerosis
Publicado: (1925)

Arteriosclerosis
Publicado: (1913)

Protective effect of rivaroxaban on arteriosclerosis obliterans in rats through modulation of the toll-like receptor 4/NF-κB signaling pathway
por: Lou, Xinjiang, et al.
Publicado: (2019)

Clinical evaluation of Alprostadil combined with Nimodipine in treatment of Cerebral Vasospasm after Subarachnoid Hemorrhage in elderly patients
por: Liu, Sisi, et al.
Publicado: (2023)

TurboHawk plaque rotation system for treatment of arteriosclerosis occlusion in lower extremities: A pilot retrospective study
por: Yuan, Zhao, et al.
Publicado: (2021)

Efficacy of administrative intervention for neurosurgical patients with off-label use of alprostadil lipid microsphere
por: Luo, Yuling, et al.
Publicado: (2022)

Covid 19 induced sildenafil lack efficacy is optimally improved by intra-urethral alprostadil
por: Coca, Vasile
Publicado: (2022)

Covid 19 induced sildenafil lack efficacy is optimally improved by intra-urethral alprostadil
por: Coca, Dr. Vasile
Publicado: (2022)

Prospective analysis of the efficacy of beraprost sodium combined with alprostadil on diabetic nephropathy and influence on rennin-angiotensin system and TNF-α
por: Xu, Xinwei, et al.
Publicado: (2020)

STUDIES OF THE PLASMIN SYSTEM : II. INHIBITION OF PLASMIN BY SERUM OR PLASMA
por: Norman, Philip S.
Publicado: (1958)

Cannot write session to /tmp/vufind_sessions/sess_g3ap3niad599oipdgifl4k8j70